Evidence map›Paper›PMID 24550499›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Inhibition of Cullin-RING E3 ubiquitin ligase 7 by simian virus 40 large T antigen.

Thomas Hartmann, Xinsong Xu, Mira Kronast, Susanne Muehlich, Kathleen Meyer, Wolfgang Zimmermann, Jerard Hurwitz, Zhen-Qiang Pan, Stefan Engelhardt, Antonio Sarikas

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Cullin-RING E3 Ubiquitin Ligase 7 in Growth Control and Cancer.Advances in experimental medicine and biology · 2020
    Review
  6. Article
  7. Article
  8. Review
  9. Poly-ubiquitination in TNFR1-mediated necroptosis.Cellular and molecular life sciences : CMLS · 2016
    Review
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Thomas HartmannInstitute of Pharmacology and Toxicology, Technische Universität München, 80802 Munich, Germany.
Xinsong Xu
Mira Kronast
Susanne Muehlich
Kathleen Meyer
Wolfgang Zimmermann
Jerard Hurwitz
Zhen-Qiang Pan
Stefan Engelhardt
Antonio Sarikas
Technical University of Munich · DELudwig-Maximilians-Universität München · DEIcahn School of Medicine at Mount Sinai · USMemorial Sloan Kettering Cancer Center · US

Funding

Studies on ROC1-dependent Ubiquitin E3 LigasesR01GM061051 · NIGMS · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI PAN, ZHEN-QIANG · 2002 to 2014
$3.4M
The function and regulation of the cullin family E3 ubiquitin ligasesR01CA095634 · NCI · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI PAN, ZHEN-QIANG · 2003 to 2012
$2.7M
NCI NIH HHS CA095634NCI NIH HHS R01 CA095634NIGMS NIH HHS GM61051NIGMS NIH HHS R01 GM061051
6 · The paper itself

Abstract

Simian virus 40 (SV40) large tumor antigen (LT) triggers oncogenic transformation by inhibition of key tumor suppressor proteins, including p53 and members of the retinoblastoma family. In addition, SV40 transformation requires binding of LT to Cullin 7 (CUL7), a core component of Cullin-RING E3 ubiquitin ligase 7 (CRL7). However, the pathomechanistic effects of LT-CUL7 interaction are mostly unknown. Here we report both in vitro and in vivo experimental evidence that SV40 LT suppresses the ubiquitin ligase function of CRL7. We show that SV40 LT, but not a CUL7 binding-deficient mutant (LT(Δ69-83)), impaired 26S proteasome-dependent proteolysis of the CRL7 target protein insulin receptor substrate 1 (IRS1), a component of the insulin and insulin-like growth factor 1 signaling pathway. SV40 LT expression resulted in the accumulation and prolonged half-life of IRS1. In vitro, purified SV40 LT reduced CRL7-dependent IRS1 ubiquitination in a concentration-dependent manner. Expression of SV40 LT, or depletion of CUL7 by RNA interference, resulted in the enhanced activation of IRS1 downstream signaling pathways phosphatidylinositol-3-kinase/AKT and Erk mitogen-activated pathway kinase, as well as up-regulation of the downstream target gene c-fos. Finally, SV40 LT-positive carcinoma of carcinoembryonic antigen 424/SV40 LT transgenic mice displayed elevated IRS1 protein levels and activation of downstream signaling. Taken together, these data suggest that SV40 LT protects IRS1 from CRL7-mediated degradation, thereby sustaining high levels of promitogenic IRS1 downstream signaling pathways.

Indexed as

Analysis of VarianceAnimalsAntigens, Viral, TumorCullin ProteinsElectrophoresis, Polyacrylamide GelHEK293 CellsHumansImmunoprecipitationInsulin Receptor Substrate ProteinsMiceMice, TransgenicMicroscopyMicroscopy, FluorescenceProteolysisRNA InterferenceSignal TransductionAntigens, Viral, TumorCUL7 protein, humanCullin ProteinsInsulin Receptor Substrate ProteinsIRS1 protein, humanUbiquitin

Identifiers

PMID24550499
PMCPMC3948260
OpenAlexW1990823259

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.